SMTL ID : 3mvl.2 (1 other biounit)

P38 Alpha Map Kinase complexed with pyrrolotriazine inhibitor 7K

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.80 Å

Oligo State

monomer

Ligands

1 x 38P: 4-{[5-(cyclopropylcarbamoyl)-2-methylphenyl]amino}-5-methyl-N-propylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide(Non-covalent)

38P.1: 19 residues within 4Å: Chain A: G.39, V.44, A.57, K.59, E.77, L.80, L.81, I.90, T.112, H.113, L.114, M.115, A.117, D.118, A.163, L.173, D.174, F.175, L.177 17 PLIP interactions: 17 interactions with chain A Hydrophobic interactions: A:A.57, A:K.59, A:L.80, A:L.81, A:L.81, A:I.90, A:T.112, A:D.118, A:L.173, A:L.173, A:F.175, A:L.177 Hydrogen bonds: A:E.77, A:E.77, A:M.115, A:D.174 pi-Cation interactions: A:K.59

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Liu, C. et al., Discovery of 4-(5-(Cyclopropylcarbamoyl)-2-Methylphenylamino)-5-Methyl-Npropylpyrrolo[1,2-F][1,2,4] Triazine-6-Carboxamide (Bms-582949), a Clinical P38 Map Kinase Inhibitor for the Treatment of Inflammatory Diseases. J.Med.Chem. (2010)

Release Date

2010-10-13

Peptides

Mitogen-activated protein kinase 14: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Mitogen-activated protein kinase 14

Related Entries With Identical Sequence